Combined Synopsis/Solicitation for Illumina Maintenance Service
ID: 75D30125Q78540Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Electronic and Precision Equipment Repair and Maintenance (811210)

PSC

MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT (J066)
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source firm fixed-price contract for maintenance services of Illumina NovaSeq 6000 and MiSeq sequencing instruments. The procurement aims to ensure the availability of manufacturer-approved repair and maintenance services, which are critical for supporting outbreak studies and public health emergencies, with a performance period from December 7, 2024, to December 6, 2025. This contract is essential for the CDC's Genomic Sequencing Laboratory (GSL) to maintain high-quality operations, particularly during times of increased demand for sequencing services. Interested parties must submit their proposals to James Brown III at xvn8@cdc.gov by 12:00 P.M. EDT on October 21, 2024, with an estimated contract value of $144,910.12.

    Point(s) of Contact
    James Brown III
    xvn8@cdc.gov
    Eric Lyons
    kpy2@cdc.gov
    Files
    Title
    Posted
    This solicitation by the Centers for Disease Control and Prevention (CDC) seeks quotes for a maintenance service contract for Illumina NovaSeq 6000 and MiSeq sequencing instruments, with a performance period from December 7, 2024, to December 6, 2025. The contract, categorized under NAICS code 811219, is structured as a firm-fixed-price purchase. It outlines requirements for repair and maintenance services, emphasizing the need for manufacturer-approved parts, prompt on-site repair responses within two business days, and annual preventive maintenance. The CDC's Genomic Sequencing Laboratory (GSL) plays a vital role in sequencing for various programs, necessitating high-quality maintenance services to manage a high volume of samples, particularly from disease outbreaks. Offerors must adhere to applicable Federal Acquisition Regulation (FAR) provisions and be registered in the System for Award Management (SAM). Interested parties are to submit their proposals to a designated CDC official by October 21, 2024. The document highlights compliance, regulatory clauses, deliverables, and communication protocols, ensuring that contractor personnel maintain clear identification as non-government employees during all interactions.
    The document outlines the justification for a sole source procurement by the Centers for Disease Control and Prevention (CDC) for maintenance, repair, and support of the Illumina NovaSeq 6000 and MiSeq instruments, estimated at $144,910.12. The procurement must follow FAR regulations, specifically FAR 13.106-1(b) and FAR 8.405-6, which permit acquisitions from a single source under compelling circumstances. The justification includes the necessity for compatibility and continuity of support for instruments critical during public health emergencies. Direct support from the manufacturer is emphasized as essential due to the urgency of repairs and the rapid response required for outbreak studies, while third-party services are deemed insufficient due to longer timelines and procedural delays. The program office, represented by Faye Rashid, certifies that the justification is accurate and necessary for non-competitive action. The contracting officer must also validate this justification for it to proceed, ensuring that federal regulations for sole source procurement are adhered to, thereby underscoring the efficiency of operations within the CDC during public health crises.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    NOTICE OF INTENT FOR iSEQ 100 ADVANCE, Mi SEQ, AND NEXT SEQ 2000 SILVER SUPPORT PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source contract with Illumina for a Silver Support Plan covering specific laboratory equipment, including the Nextseq 2000 and MiSeq systems. This support plan includes comprehensive services such as full coverage for parts, labor, and travel, OEM parts and service, reagent replacement due to equipment failures, scheduled maintenance visits, remote technical support, and timely on-site response, all over a 12-month term billed quarterly. The procurement is critical for maintaining the operational efficiency of NIAID's laboratory capabilities, ensuring that essential equipment remains functional and supported. Interested vendors must submit their responses via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 23, 2024, at 10:00 AM EST, and should direct any inquiries to Leah Hinson at leah.hinson@nih.gov.
    J--NICHD: Service: PacBio Sequel II Service Agreement
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Child Health and Human Development (NICHD), intends to award a sole source contract to Pacific Biosciences of California for a PacBio Sequel II Service Agreement. This procurement is essential for maintaining two advanced PacBio sequencers that are critical for NICHD researchers, ensuring their reliable operation while minimizing downtime and repair costs. The contract will cover one year of service, including preventive maintenance, software updates, remote diagnostics, and the provision of necessary reagents, with a performance period from January 11, 2025, to January 10, 2026, and the possibility of three option years. Interested parties are encouraged to submit their interest and capabilities by December 27, 2024, to determine if a competitive procurement process will be initiated. For further inquiries, contact Nicole T. Freid at nicole.freid@nih.gov or +1 301 480 6914.
    CDC DFWED NARST Sensititre Supplies
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    QIACube Maintenance Agreement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for a maintenance agreement for its QIACube system, essential for the Atlanta Human and Animal Food Laboratory's molecular biology operations. The procurement requires a comprehensive service agreement that includes repair, labor, travel, and a loaner instrument, ensuring compliance with ISO accreditation standards and continuity in critical DNA and RNA extraction processes. The contract will commence on February 1, 2025, and run for one year, with options for four additional years, and proposals are due by 11:59 PM EST on January 3, 2025. Interested vendors can contact James O’Keefe at 301-796-7371 or via email at James.OKeefeIII@fda.hhs.gov for further information.
    Cytiva Sefia S-2000 Cell Processing Instrument Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole source contract to Global Life Sciences Solutions USA LLC for preventative maintenance services on three Cytiva Sefia S-2000 Cell Processing Instruments located at the NIH Clinical Center in Bethesda, Maryland. The contract will cover unlimited service repair and preventive maintenance for these critical instruments used in cell therapy manufacturing and research, which are essential for compliance with FDA regulations regarding the maintenance of equipment used in drug product manufacturing. Interested parties capable of providing similar services may submit a capability statement by December 29, 2024, at 12:00 pm EST to Sheri Eiri at sheri.eiri@nih.gov for consideration in the procurement process.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    MAINTENANCE OF CYTEK AURORA 5 FLOW CYTOMETER
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified contractors for the maintenance of a Cytek Aurora 5 flow cytometer, a critical instrument used in viral disease research. The procurement includes comprehensive maintenance services for a one-year period, which encompasses preventive maintenance inspections, guaranteed response times for technical support, and unlimited service visits, ensuring the equipment remains operational for ongoing scientific investigations. This opportunity is vital for the Laboratory of Viral Diseases at NIH, which relies on such equipment for data collection and analysis in their research on viral pathogenesis and host defense mechanisms. Interested vendors must submit their quotes by December 23, 2024, at 12:00 PM EST, and can contact Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov for further information.
    Molecular HIV-PCR Test Equipment Maintenance
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole source contract for the maintenance of Molecular HIV-PCR Test Equipment, specifically targeting Roche Diagnostics Corp. This procurement involves the provision of microbiology molecular diagnostics reagents and analyzer rental, including the Roche 6800 and Cobas Prime pre-analytical instruments, along with maintenance and emergency services for the equipment. The contract is crucial for supporting analytical services related to various infectious diseases, including HIV and COVID-19, and is expected to be finalized by February 2, 2025. Interested parties must submit evidence of capability by December 26, 2024, to Alecia Mitchell at alecia.mitchell@va.gov, as the government retains discretion on whether to compete the procurement.
    CHROMIUM IX/X AND VISIUM CYTASSIT ASSURANCE PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a sole-source contract with 10X Genomics, Inc. for a warranty and maintenance agreement for their Chromium X and CytAssist instruments. This procurement is critical as these instruments are essential for conducting advanced single-cell sequencing and spatial transcriptomics research, which supports the development of new diagnostics, therapeutics, and vaccines against human diseases. The maintenance agreement will ensure uninterrupted operation of these technologies, which are vital for NIAID researchers, and interested vendors must submit their capabilities statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 PM EST on December 30, 2024. For further inquiries, vendors can contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D. Weidow at weidowjd@niaid.nih.gov.
    cDNA-PCR Sequencing Kits for long-read sequencing.
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of cDNA-PCR Sequencing Kits for long-read sequencing, as part of a combined synopsis/solicitation. The primary objective is to acquire Promethion Flow Cell packs and sequencing kits to support high-throughput sequencing efforts aimed at advancing research on neurodegenerative diseases, particularly Alzheimer's disease. This procurement is crucial for the Center for Alzheimer’s Disease and Related Dementias (CARD) and is expected to facilitate the identification of causative genes and potential therapeutic targets. Interested vendors must submit their quotations by 5:00 p.m. Eastern Time on December 30, 2024, referencing Solicitation Number 75N95025Q00008, and can direct inquiries to Iris Merscher at iris.merscher@nih.gov or by phone at 301-827-2547.